Roquefort Therapeutics (ROQ) News Today → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free ROQ Stock Alerts GBX 4.60 +0.05 (+1.10%) (As of 03:51 AM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineRoquefort Therapeutics (LON:ROQ) Trading Down 1.1%americanbankingnews.com - April 19 at 2:58 AMUK Stocks: Here’s Why Roquefort (ROQ) Share Price is Crashingmsn.com - April 5 at 6:41 PMRoquefort celebrates "significant milestones" in cancer researchlse.co.uk - March 11 at 12:20 PMRoquefort Therapeutics reveals progress with liver and colorectal cancer programmesuk.investing.com - March 11 at 7:20 AMNBSE NeuBase Therapeutics, Inc.seekingalpha.com - December 21 at 5:36 PMRoquefort Therapeutics MK cell programme shows positive resultslse.co.uk - November 6 at 8:48 AMRoquefort Therapeutics preparing targets for clinic as eyes commercial dealsproactiveinvestors.com - September 27 at 9:23 AMRoquefort Therapeutics preparing targets for clinic as it eyes commercial dealsproactiveinvestors.com - September 27 at 9:23 AMRoquefort Therapeutics seeks to lock in future value with anti-cancer therapeutic patentsfinance.yahoo.com - August 17 at 4:33 PMRoquefort Therapeutics making headway with siRNAfinance.yahoo.com - August 9 at 8:19 AMRoquefort Therapeutics highlights significant progress at AGMproactiveinvestors.com - June 29 at 8:13 AMRoquefort Therapeutics hails significant pre-clinical resultsproactiveinvestors.com - June 22 at 7:55 AMRoquefort Therapeutics Makes Progress on Cancer Treatmentmarketwatch.com - June 22 at 7:55 AMRoquefort Therapeutics returns to the market with new study datafinance.yahoo.com - June 16 at 8:42 AMRoquefort Therapeutics' Anti-Cancer MRNA Study Showed Positive Resultsmarketwatch.com - June 13 at 4:17 AMRoquefort Therapeutics Resumes Trading After Publishing 2022 Resultsmarketwatch.com - June 7 at 8:57 AMRoquefort Therapeutics eyes second half progressproactiveinvestors.com - June 5 at 8:31 AMRoquefort Therapeutics has no exposure to SVBproactiveinvestors.com - March 13 at 8:10 AMRoquefort Therapeutics says new mRNA platform "fits very well"proactiveinvestors.com - March 8 at 8:12 AMRoquefort develops a fifth programme using a technology pioneered by Moderna and BioNTechproactiveinvestors.com - March 8 at 3:11 AMRoquefort Therapeutics establishes scientific advisory boardproactiveinvestors.com - March 6 at 11:07 AMRoquefort Thera Regulatory Newslse.co.uk - February 22 at 10:44 AMRoquefort Therapeutics PLCbarrons.com - February 21 at 8:35 AMRoquefort Therapeutics inks Randox diagnostic dealproactiveinvestors.com - February 20 at 10:03 AMRoquefort Therapeutics inks first strategic licensing deal with diagnostics firm Randoxproactiveinvestors.com - February 20 at 10:03 AMRoquefort Therapeutics demonstrates initial safety in two antibody programmesfinance.yahoo.com - January 26 at 7:21 AMRoquefort Therapeutics demonstrates safety in two antibody programmesproactiveinvestors.com - January 24 at 11:02 AMRoquefort Therapeutics cancer drugs enjoy pre-clinical successproactiveinvestors.com - January 24 at 11:02 AMRoquefort Therapeutics CEO lays out strategy for 2023proactiveinvestors.com - January 9 at 8:31 AMRoquefort Therapeutics in out-licensing discussions with 'multiple' large bio-pharma companiesproactiveinvestors.com - January 9 at 8:31 AMRoquefort Therapeutics to present breakthrough RNA cancer study results at key conferenceproactiveinvestors.com - October 11 at 10:55 AMRoquefort Therapeutics explains the significance of its "very exciting" cancer drug study resultsproactiveinvestors.com - October 11 at 10:55 AMStratford-upon-Avon company bought in multi-million pound dealmsn.com - September 21 at 9:25 AMBiotech firm Oncogeni acquired in £5.5m dealmsn.com - September 20 at 2:49 AMUK Retailers Drop After August Sales Slumpmorningstar.com - September 17 at 6:36 PMRoquefort enlists Nobel prizewinner Sir Martin Evansthetimes.co.uk - September 16 at 9:29 PMFTSE 100 opens lower as world bank warns of recession.proactiveinvestors.com - September 16 at 10:26 AMRoquefort Therapeutics plc (ROQ.L)uk.finance.yahoo.com - September 2 at 10:17 PMRoquefort Investments PLC (ROQ)investing.com - August 20 at 11:16 PMRoquefort Therapeutics PLC Announces Commencement of Trading on US OTCQB Venture Marketfinance.yahoo.com - July 15 at 3:28 AM Get Roquefort Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ROQ and its competitors with MarketBeat's FREE daily newsletter. Email Address World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea. Click here to find out what to do. ROQ Media Mentions By Week ROQ Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ROQ News Sentiment▼0.000.39▲Average Medical News Sentiment ROQ News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ROQ Articles This Week▼10▲ROQ Articles Average Week Get Roquefort Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ROQ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: VAL News IXI News OCTP News FAB News IMM News BVX News EVG News RENE News PYC News SNG News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:ROQ) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsThe World's First "$20 Trillion Drug?"Behind the MarketsI’m afraid WWIII is a very real possibility Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roquefort Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
